
This Task Force will address the definition of treatment resistant bipolar depression and provide guidance on clinical trial design, methodology, and optimal endpoints for regulatory bodies, investigators and clinicians, to improve awareness, advance science, and deliver better treatments for this condition.


Objectives
- Coming soon!
Leads
Eduard Vieta,
Spain
Members of Task Force
Ana Andreazza, Canada
Gerard Anmella, Spain
Michael Bauer, Germany
Michael Berk, Australia
Harriet Birabwa-Oketcho, Uganda
Paolo Brambilla, Italy
Wieslaw J. Cubala, Poland
Olivia Dean, Australia
Giovanna Fico, Spain
Brisa Frenandes, USA
Ana Gonzalez-Pinto, Spain
Kyooseob Ha, Canada/South Korea
Chantal Henry, France
Diego Hidalgo-Mazzei, Spain
Carlos Lopez-Jaramillo, Colombia
Roger McIntyre, Canada
Kamilla Miskowiak, Denmark
Andrew Nierenberg, USA
Paula Nunes, Canada/Brazil
Aysegul Ozerdem, USA
Isabella Pacchiarotti, Spain
Maja Pantovic Stefanovic, Serbia
Robert Post, USA
Balwinder Singh, USA
Jair Soares, USA
Trisha Suppes, USA
Holly Swartz, USA
Mauricio Tohen, USA
Tamsyn Van Rheenen, Australia
Lakshmi Yatham, Canada
Allan Young, UK
Task Force Updates
Publications:
2025
Vieta, E., McIntyre, R.S., Suppes, T., Van Rheenen, T.E., Singh, B., Miskowiak, K.W., Young, A.H., Yatham, L.N., Ha, K., Berk, M., Swartz, H.A., Henry, C., Stefanovic, M.P., Diaz, G.A., Ozerdem, A., Cubała, W.J., Hidalgo-Mazzei, D., Tohen, M., Pacchiarotti, I., Nunes, P.V., Lopez-Jaramillo, C., Gonzalez-Pinto, A., Brambilla, P., Post, R., Soares, J.C., Bauer, M., Andreazza, A.C., Fradera, X.J., Cosials-Lopez, M. and Fico, G. (2025), Defining Treatment-Resistant Bipolar Depression: Recommendations From the ISBD Task Force. Bipolar Disord, 27: 411-423.



